日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Comparison of the real-world efficacy and safety of romiplostim and recombinant human thrombopoietin (rhTPO) in chemotherapy-induced thrombocytopenia

比较罗米司亭和重组人血小板生成素（rhTPO）在化疗引起的血小板减少症中的真实世界疗效和安全性

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-026-15678-z
Cheng, Yu; Wei, Juan; Zhu, Fang; Xuan, Liang; Li, Yuan; Meng, Lei; Zhu, Chuandong; Zhao, Huihui
血小板
TPO
发表日期：2026
文献求助 收藏

Enhanced Photocatalytic Performance of Halogenated Phenylacetylene-Decorated Cu(2)O Surfaces via Electronic Structure Modulation: A DFT and Experimental Study

通过电子结构调控增强卤代苯乙炔修饰的Cu(2)O表面的光催化性能：DFT和实验研究

期刊:ACS Nanoscience Au
影响因子:6.3
doi:10.1021/acsnanoscienceau.5c00030
Kao, Jui-Cheng; Yu, Wei-Yang; Chien, Kuo-Chang; Chou, Po-Jung; Huang, Michael H; Lo, Yu-Chieh; Chou, Jyh-Pin
信号转导
发表日期：2025
文献求助 收藏

Hippocampal NLRP1 inflammasome mediates anxiety-like behavior in mice with hypothyroidism.

海马 NLRP1 炎症小体介导甲状腺功能减退小鼠的焦虑样行为

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-00979-3
Cheng Yu-Wei, Zou Zhi-Hui, Lou Chen-Lu, Tong Ming-Rui, Li Jin-Kai, Zhu Wen-Hui, Lu Yu-Lin, Zhu De-Fa, Xu Qi, Xu Yong-Xia
炎症/感染
Hippo
炎症
发表日期：2025
文献求助 收藏

Real-World Effectiveness and Safety of Immune Checkpoint Inhibitors Combined with Chemotherapy in Taiwanese Patients with Extensive-Stage Small Cell Lung Cancer

免疫检查点抑制剂联合化疗治疗台湾广泛期小细胞肺癌患者的真实世界疗效和安全性

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol32080472
Chang, Cheng-Yu; Wei, Yu-Feng; Chang, Shih-Chieh; Chen, Chung-Yu
Checkpoint
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Mortality Outcome Associated with Specific KRAS, NRAS, and BRAF Hot-Spot Mutations in Metastatic Colorectal Cancer Patients: A Retrospective Cohort Study

转移性结直肠癌患者中特定KRAS、NRAS和BRAF热点突变与死亡结局的相关性：一项回顾性队列研究

期刊:Diagnostics
影响因子:3.3
doi:10.3390/diagnostics15050590
Abdelgadir, Omer; Kuo, Yong-Fang; Khan, M Firoze; Okorodudu, Anthony O; Cheng, Yu-Wei; Dong, Jianli
BRAF
肿瘤
肠癌
RAS
肿瘤免疫
发表日期：2025
文献求助 收藏

KRAS, NRAS, and BRAF Hot-Spot Mutations in Relation to Sidedness of Primary Colorectal Cancer: A Retrospective Cohort Study

KRAS、NRAS 和 BRAF 热点突变与原发性结直肠癌侧别的关系：一项回顾性队列研究

期刊:Diagnostics
影响因子:3.3
doi:10.3390/diagnostics15020142
Abdelgadir, Omer; Kuo, Yong-Fang; Okorodudu, Anthony O; Khan, M Firoze; Cheng, Yu-Wei; Dong, Jianli
肿瘤
肠癌
肿瘤免疫
BRAF
RAS
发表日期：2025
文献求助 收藏

Clinical features and outcomes of first-line EGFR-TKI treatment in younger and older patients with EGFR-mutated NSCLC

EGFR突变型非小细胞肺癌患者一线EGFR-TKI治疗的临床特征和疗效（年轻患者和老年患者）

期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2025.2514422
Lai, Yi-Chun; Chang, Cheng-Yu; Wei, Yu-Feng; Chen, Chung-Yu; Chang, Shih-Chieh
EGFR
肺癌
EGF
肿瘤
细胞生物学
肿瘤免疫
发表日期：2025
文献求助 收藏

A Chemotherapy Responsive Ewing Sarcoma Case Report With a Rare FUS::FLI1 Fusion

一例对化疗敏感的尤文氏肉瘤病例报告，伴有罕见的FUS::FLI1融合基因

期刊:Case Reports in Pathology
影响因子:0.5
doi:10.1155/crip/8844406
Elbaz Younes, Ismail M; Budd, G Thomas; Cheng, Yu-Wei
FUS
发表日期：2025
文献求助 收藏

Colorectal cancer tumor phenotypes associated with KRAS, NRAS, and BRAF hot-spot mutations

与KRAS、NRAS和BRAF热点突变相关的结直肠癌肿瘤表型

期刊:
影响因子:
doi:10.4291/wjgp.v16.i3.107954
Abdelgadir, Omer; Kuo, Yong-Fang; Khan, M Firoze; Okorodudu, Anthony O; Cheng, Yu-Wei O; Dong, Jianli
肿瘤
肠癌
肿瘤免疫
BRAF
RAS
发表日期：2025
文献求助 收藏

The AKT2/SIRT5/TFEB pathway as a potential therapeutic target in non-neovascular AMD

AKT2/SIRT5/TFEB 通路作为非新生血管性 AMD 的潜在治疗靶点

期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-024-50500-z
Sayan Ghosh, Ruchi Sharma, Sridhar Bammidi, Victoria Koontz, Mihir Nemani, Meysam Yazdankhah, Katarzyna M Kedziora, Donna Beer Stolz, Callen T Wallace, Cheng Yu-Wei, Jonathan Franks, Devika Bose, Peng Shang, Helena M Ambrosino, James R Dutton, Zhaohui Geng, Jair Montford, Jiwon Ryu, Dhivyaa Rajasund
信号转导
ELISA
PI3K/Akt
TFEB
发表日期：2024
文献求助 收藏